Overview
How Lung Cancer Presents
Lung cancer begins when abnormal cells in the bronchial or alveolar tissues multiply without normal growth control.
REx-PN
REx-PN
Lung cancer begins when abnormal cells in the bronchial or alveolar tissues multiply without normal growth control. A tumour may narrow an airway, invade nearby structures, cause bleeding, or stimulate pleural-fluid formation. Spread through lymphatic or blood vessels produces disease in lymph nodes and distant organs, so the same patient may have both respiratory symptoms and bone, neurologic, or constitutional findings. Non-small-cell lung cancer (NSCLC) is the more common group. Small-cell lung cancer (SCLC) generally grows and spreads more rapidly, which helps explain why treatment decisions depend heavily on both histology and stage. Early disease may cause no symptoms. As a tumour enlarges, common findings include a persistent or changing cough, hemoptysis, dyspnea, wheeze, chest discomfort, hoarseness, recurrent pneumonia in the same area, fatigue, anorexia, and unintentional weight loss. These findings are not specific to cancer: COPD, infection, pulmonary embolism, and heart failure can look similar. A cough that is new, progressive, associated with blood, or different from a patient’s usual COPD cough deserves assessment rather than reassurance. Risk rises with tobacco exposure, second-hand smoke, radon, and occupational inhalants such...
Unlock full lesson + practice questions
8 more sections with scenarios, priorities, and review drills.
Final rapid review before practice
Next study step
Finish the lesson first, then choose a focused activity to apply what you just reviewed.
Continue studying
Sign in to save progress on this lesson.
Unlock the interactive lesson quiz with a plan that includes this REx-PN pathway. You can still explore topic-filtered questions from the bank hubs below.